1. Archives
  2. Magazine - 25 Apr 2024

  3. All eyes on sales momentum for Eli Lilly’s obesity drug Zepbound

Demand for the group’s products may exceed supply again this year

|Week Ahead|by Martin Gamble
Eli Lilly sign on top of office building
< Retail giant Next sees strong first-quarter full-price sales increase
UK housing market springs a surprise but all eyes still turned to the US >
Issue: 25 Apr 2024 - Page 12 |
Contents
Next:
UK housing market springs a surprise but all eyes still turned to the US
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo
Martin Gamble profile pic
Martin Gamble

Issue Contents

Retail giant Next sees strong first-quarter full-price sales increase
All eyes on sales momentum for Eli Lilly’s obesity drug Zepbound
UK housing market springs a surprise but all eyes still turned to the US

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of directors' buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
27 Mar 2025 Subscribe now

Market Overview

UK 350 Risers and Fallers

Issue Contents

Retail giant Next sees strong first-quarter full-price sales increase
All eyes on sales momentum for Eli Lilly’s obesity drug Zepbound
UK housing market springs a surprise but all eyes still turned to the US